Scarica l'app Stockscreener
38.88
0.65%
0.25
Dopo l'orario di chiusura:
38.88
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CSTL Giù?
Forum
Previsione
Precedente Chiudi:
$38.63
Aprire:
$39.05
Volume 24 ore:
393.22K
Relative Volume:
0.99
Capitalizzazione di mercato:
$1.13B
Reddito:
$219.79M
Utile/perdita netta:
$-57.47M
Rapporto P/E:
-18.08
EPS:
-2.15
Flusso di cassa netto:
$-19.25M
1 W Prestazione:
+2.05%
1M Prestazione:
+16.23%
6M Prestazione:
+107.36%
1 anno Prestazione:
+34.67%
Intervallo 1D:
$38.24
$39.53
Intervallo di 1 settimana:
$36.63
$39.53
Portata 52W:
$14.59
$40.61
Castle Biosciences Inc Stock (CSTL) Company Profile
Nome
Castle Biosciences Inc
Settore
Industria
Telefono
866-788-9007
Indirizzo
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Confronta CSTL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
38.88 | 1.13B | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
575.91 | 215.01B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
228.53 | 159.87B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
700.55 | 56.23B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
140.60 | 39.54B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
223.63 | 37.85B | 15.90B | 1.28B | 2.21B | 7.2842 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2021-04-30 | Iniziato | Lake Street | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | Reiterato | Canaccord Genuity | Buy |
| 2019-08-19 | Iniziato | BTIG Research | Buy |
| 2019-08-19 | Iniziato | Canaccord Genuity | Buy |
| 2019-08-19 | Iniziato | Robert W. Baird | Outperform |
| 2019-08-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Castle Biosciences Inc Borsa (CSTL) Ultime notizie
Castle Biosciences (NASDAQ:CSTL) Given New $50.00 Price Target at BTIG Research - MarketBeat
Castle Biosciences, Inc. $CSTL Shares Bought by Braidwell LP - MarketBeat
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Castle Biosciences (CSTL) Highlights Breakthrough in Barrett's E - GuruFocus
Castle Biosciences Announces Publication of Study Confirming TissueCypher® Test's Efficacy in Risk Stratification for Barrett's Esophagus Patients - Quiver Quantitative
BTIG Maintains Castle Biosciences (CSTL) Buy Recommendation - Nasdaq
Systematic Review and Meta-Analysis Confirms TissueCypher® - GlobeNewswire
Expert Melanoma Panel Recommends Castle Biosciences DecisionDx-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma - marketscreener.com
Castle Biosciences Announces Endorsement of DecisionDx-Melanoma Test in Independent Expert Consensus Paper - Quiver Quantitative
Expert Melanoma Panel Recommends Castle Biosciences’ - GlobeNewswire
Castle Biosciences (NASDAQ:CSTL) Insider Sells $53,600.17 in Stock - MarketBeat
Here's Why 'Trend' Investors Would Love Betting on Castle Biosciences (CSTL) - Yahoo Finance
New York State Common Retirement Fund Acquires 52,671 Shares of Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences, Inc. $CSTL Shares Purchased by Schroder Investment Management Group - MarketBeat
Will Castle Biosciences Inc. stock attract more institutional investorsFed Meeting & Reliable Price Breakout Signals - Newser
XTX Topco Ltd Increases Stock Holdings in Castle Biosciences, Inc. $CSTL - MarketBeat
Geode Capital Management LLC Boosts Stake in Castle Biosciences, Inc. $CSTL - MarketBeat
8,362 Shares in Castle Biosciences, Inc. $CSTL Purchased by Elevation Point Wealth Partners LLC - MarketBeat
Castle Biosciences stock hits 52-week high at 40.61 USD By Investing.com - Investing.com Australia
Castle Biosciences stock hits 52-week high at 40.61 USD - Investing.com
Summit Global Investments Lowers Stake in Castle Biosciences, Inc. $CSTL - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Grows Stock Position in Castle Biosciences, Inc. $CSTL - MarketBeat
Derek Maetzold Sells 5,115 Shares of Castle Biosciences (NASDAQ:CSTL) Stock - MarketBeat
Is Castle Biosciences Inc. stock a buy before product launches2025 Analyst Calls & Fast Entry Momentum Trade Alerts - BỘ NỘI VỤ
Castle Biosciences (NASDAQ:CSTL) Hits New 52-Week HighTime to Buy? - MarketBeat
CSTL Form 4: CEO stock sale and updated insider holdings - Stock Titan
Castle Biosciences (NASDAQ:CSTL) Insider Tobin Juvenal Sells 4,693 Shares - MarketBeat
CEO Maetzold Files To Sell 10,712 Of Castle Biosciences Inc [CSTL] - TradingView
How Much Upside is Left in Castle Biosciences (CSTL)? Wall Street Analysts Think 50.08% - MSN
Castle Biosciences Executive Sells Shares - TradingView
Officer Juvenal Sells 4,693 ($167K) Of Castle Biosciences Inc [CSTL] - TradingView
[Form 4] CASTLE BIOSCIENCES INC Insider Trading Activity - Stock Titan
Top 5 Articles of the Week: November 16-21 - Dermatology Times
Is Pune Es Valuation Cheap Compared to Growth PeersChart Pattern Recognition & Superior Wealth Building - earlytimes.in
Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Castle Biosciences partners with SciBase for diagnostic tests - MSN
What Makes Castle Biosciences (CSTL) a New Strong Buy Stock - MSN
Castle Biosciences, Inc. (086.F) stock price, news, quote and history - Yahoo Finance UK
Castle Biosciences (NASDAQ:CSTL) Sets New 1-Year HighTime to Buy? - MarketBeat
Castle Biosciences stock hits 52-week high at $35.68 By Investing.com - Investing.com Canada
Does New Melanoma Data Redefine the Bull Case for Castle Biosciences' DecisionDx Platform (CSTL)? - Yahoo Finance
Castle Biosciences stock hits 52-week high at $35.68 - Investing.com
Can Castle Biosciences Inc. stock deliver consistent earnings growthJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com
Castle Biosciences earns Houston Top Workplace title for fifth year - Traders Union
Castle Biosciences (CSTL): Evaluating Valuation as New Melanoma Test Data Gains Attention at Major Oncology Congress - Yahoo Finance
Castle Biosciences, Inc. (CSTL) Reports Next Week: Wall Street Expects Earnings Growth - MSN
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Castle Biosciences, Inc. (CSTL) Competitors - Meyka
Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year - The Manila Times
Zacks.com featured highlights include Perimeter Solutions, Interface, Castle Biosciences and Great Lakes Dredge & Dock - sharewise.com
Castle Biosciences, Inc. $CSTL Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Castle Biosciences Inc Azioni (CSTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.04%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):